Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging

Radiology. 1996 Oct;201(1):185-93. doi: 10.1148/radiology.201.1.8816542.

Abstract

Purpose: To evaluate contrast enhancement patterns of urinary bladder cancer and surrounding structures and to evaluate a fast dynamic first-pass magnetic resonance (MR) imaging technique in tumor and node staging and in differentiation of urinary bladder cancer from postbiopsy effects.

Materials and methods: Sixty-one consecutive patients with histologically proved urinary bladder cancer were referred to undergo unenhanced and dynamic MR imaging 1-4 weeks after transurethral resection or biopsy. Subtraction and time (to beginning of enhancement) images were acquired.

Results: Results with unenhanced T1- and T2-weighted images were compared with those obtained with the unenhanced images plus dynamic contrast material-enhanced single-section turbo fast low-angle shot (FLASH) images. Urinary bladder cancer started to enhance 6.5 seconds +/- 3.5 (standard deviation) after the beginning of arterial enhancement, which was 4 seconds earlier than most other structures (postbiopsy tissue, 13.6 seconds +/- 4.2). In differentiation of postbiopsy tissue from malignancy on the basis of the beginning of enhancement depicted on time and subtracted images, accuracy improved from 79% to 90% (P < .02) and specificity improved from 33% to 92% (not significant). Overall, tumor staging accuracy improved significantly from 67% to 84% (P < .01) by adding the turbo FLASH images.

Conclusion: Fast dynamic first-pass MR imaging, with at least one image acquired every 2 seconds, improved delineation of urinary bladder cancer, tumor staging, and detection of metastases.

Publication types

  • Comparative Study

MeSH terms

  • Biopsy
  • Carcinoma, Transitional Cell / pathology*
  • Contrast Media
  • Drug Combinations
  • Female
  • Gadolinium DTPA
  • Humans
  • Image Processing, Computer-Assisted
  • Lymphatic Metastasis
  • Magnetic Resonance Imaging / methods
  • Male
  • Meglumine
  • Middle Aged
  • Neoplasm Staging
  • Organometallic Compounds
  • Pentetic Acid / analogs & derivatives
  • Prospective Studies
  • Sensitivity and Specificity
  • Urinary Bladder / pathology*
  • Urinary Bladder Neoplasms / pathology*

Substances

  • Contrast Media
  • Drug Combinations
  • Organometallic Compounds
  • Meglumine
  • Pentetic Acid
  • Gadolinium DTPA